Exenatide protects renal ischemia reperfusion injury in type 2 diabetes mellitus

International Journal of Diabetes in Developing Countries

Volumn 30, Issue 4, 2010, Pages 217-225

  Vaghasiya, Jitendra ^a   Sheth, Navin ^b   Bhalodia, Yagnik ^c   Shailesh, Malaviya ^c   Jivani, Nurudin ^c  

^a Jodhpur National University   (India)

^b SAURASHTRA UNIVERSITY   (India)

^c RBPMPC   (India)

Author keywords

exenatide; inflammation; ischemia reperfusion; kidney; oxidative stress; Type 2 diabetes mellitus

Indexed keywords

EID: 77958001216     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.4103/0973-3930.70863     Document Type: Article

References (45)

1. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis 2000;35:157-65.
2. Hokama JY, Ritter LS, Gorman GD, Cimetta AD, Copeland JG, McDonagh PF. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia. J Diabetes Complicat 2000;14:96-107.
3. Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: Distant dream or near reality? Heart 2000;83:381-7.
4. Yokoyama H, Okudaira M, Otani T, Sato A, Miura J, Takaike H, et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int 2000;58:302-11.
5. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC. Ischemia causes rapidly progssive nephropathy in the diabetic rat. Kidney Int 1997;52:985-91.
6. Basireddy M, Isbell TS, Teng X, Patel RP, Agarwal A. Effects of sodium nitrite on ischemia-reperfusion injury in the rat kidney. Am J Physiol Renal Physiol 2006;290: F779-86.
7. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001;281: F948-57.
8. Ysebaert DK, De Greef KE, De Beuf A, Van Rompay AR, Vercauteren S, Persy VP, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004;66:491-6.
9. Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E. An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci 2006;36:326-32.
10. Erdogan H, Fadillioglu E, Yagmurca M, Ucar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: Protective effects of erdosteine and N-acetylcysteine. Urol Res 2006;34:41-6.
11. Yild irim A, Gumus M, Dalga S, Sahin YN, Akcay F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Ann Clin Lab Sci 2003;33:459-64.
12. Emre MH, Erdogan H, Fadillioglu E. Effect of BQ-123 and nitric oxide inhibition on liver in rats after renal ischemia-reperfusion injury. Gen Physiol Biophys 2006;25:195-206.
13. Wei Y, Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 1995;358:219-24.
14. Vila Petroff MG, Egan JM, Wang X, Sollott SJ. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 2001;89:445-52.
15. Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM. Glucagonlike peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 2005;54:146-51.
16. Bose AK, Mocanu MM, Carr RD, Yellon DM. Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model. Cardiovasc Drugs Ther 2005;19:9-11.
17. Bose AK, Mocanu MM, Carr RD, Yellon DM. Myocardial Ischaemia reperofusion Injury is Attenuated by Intact Glucagon Like Peptide-1 (GLP-1) in the In Vitro Rat Heart and may Involve the p70s6K Pathway. Cardiovasc Drugs Ther 2007;21:253-6.
18. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224-9.
19. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in liver fractions in vitro. Biochem J 1971;123:805-14.
20. Moran MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica Biophysica Acta 1979;582:67-78. (Pubitemid 9065588)
21. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay of SOD. J Biol Chem 1972;247:3170-5.
22. Aebi H. Oxidoreductases acting on groups other than CHOH: Catalase. In: Colowick SP, Kaplan NO, Packer L, editors. Vol. 105. Methods in Enzymology. London: Academic Press; 1984. p. 121-5.
23. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte peroxidase. J Lab Clin Med 1967;2:158-69.
24. Prajda N, Weber G. Malign transformation-linked imbalance: Decreased XO activity in hepatomas. FEBS Lett 1975;59:245-9.
25. Guevara I, Iwanejko J, Dembinska-Kiec A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998;274:177-88.
26. Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993;14:1195-201.
27. Jan Willem J, Elisabeth K, Tom H, Bob S. Ischemic nucleotide breakdown increases during cardiac development due to drop in adenosine anabolism/catabolism ratio. Journal of Molecular and Cellular Cardiology. 1990;22(10):1065-70
28. Stromski ME, Cooper K, Thulin G, Gaudio KM, Siegel NJ, Shulman RG. Chemical and functional correlates of postischemic renal ATP levels. Proc Natl Acad Sci USA 1986;83:6142-5.
29. Zager RA. Hyperthermia: Effects on renal ischemic/reperfusion injury in the rat. Lab Invest 1990;63:360-9.
30. Aragno M, Parola S, Brignardello E, Mauro A, Tamagno E, Manti R, et al. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 2000;49:1924-31.
31. Salas A, Panes J, Elizalde JI, Granger DN, Pique JM. Reperfusioninduced oxidative stress in diabetes: Cellular and enzymatic sources. J Leukoc Biol 1999;66:59-66.
32. Panes J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P. Diabetes Exacerbates Inflammatory Responses to Ischemia-Reperfusion. Circulation 1996;93:161-7.
33. Sakr M, Zetti G, McClain C, Gavaler J, Nalesnik M, Todo S, et al. The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation 1992;53:987-91.
34. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003;14:1549-58.
35. Arnhold J, Osipov AN, Spalteholz H, Panasenko OM, Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med 2001;31:1111-9.
36. Goor Y, Peer G, Iaina A, Blum M, Wollman Y, Chernikovsky T, et al. Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia 1996;39:1036-40.
37. Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004;348:27-34. (Pubitemid 39208997)
38. Sudnikovich EJ, Maksimchik YZ, Zabrodskaya SV, Kubyshin VL, Lapshina EA, Bryszewska M, et al. Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rats. Eur J Pharmacol 2007;569:180-7.
39. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993;42:801-13.
40. Moursi M, Rising CL, Zelenock GB, D'Alecy LG. Dextrose administration exacerbates acute renal ischemic damage in anesthetized dogs. Arch Surg 1987;122:790-4.
41. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983;74:540-4.
42. Sutherland GR, Peeling J, Sutherland E, Tyson R, Dai F, Kozlowski P, et al. Forebrain ischemia in diabetic and nondiabetic BB rats studied with 31P magnetic resonance spectroscopy. Diabetes 1992;41:1328-34.
43. Timmers L, Henriques PS, De Kleijn PV, Hans De Vries J, Hans Kemperman, Cees WJ, et al. Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury. J Am Coll Cardiol 2009;53:501-10.
44. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, et al. Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol 2008;581:306-14.
45. Hyo JK, Ki WL, Mi-Sung K, Hyong JL. Piceatannol attenuates hydrogen peroxide-and peroxynitrite-induced apoptosis of PC12 cells by blocking down-regulation of Bcl-XL and activation of JNK. J Nutr Biochem 2007;7:459-66.